Current challenges in clinical target volume definition: Tumour margins and microscopic extensions

References

• International commission of radiation units and measurements. Prescribing, Recording, and Reporting Photon Beam Therapy, Report no. 50, ICRU: Bethesda;1993.
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012.CA Cancer J Clin 2012;62:10–29.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009.CA Cancer J Clin 2009;59: 225–49.
   PubMed Web of Science ®Google Scholar
• Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, . Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48:1015–24.
   PubMed Web of Science ®Google Scholar
• Graham MV, Matthews JW, Harms Sr WB, Emami B, Glazer HS, Purdy JA. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 1994;29:1105–17.
   PubMedGoogle Scholar
• Graham MV, Purdy JA, Emami B, Matthews JW, Harms WB. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995;33:993–1000.
   PubMedGoogle Scholar
• Ekberg L, Holmberg O, Wittgren L, Bjelkengren G, Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?Radiother Oncol 1998;48:71–7.
   PubMed Web of Science ®Google Scholar
• Li WL, Yu JM, Liu GH, Zhong WX, Li WW, Zhang BJ. [A comparative study on radiology and pathology target volume in non-small-cell lung cancer]. Zhonghua Zhong Liu Za Zhi 2003;25:566–8.
   PubMedGoogle Scholar
• Grills IS, Fitch DL, Goldstein NS, Yan D, Chmielewski GW, Welsh RJ, . Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:334–41.
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Muller-Hermelink HK, Harris C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon, France: IARC Press; 2004.
   Google Scholar
• Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, . Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007;67:727–34.
   Google Scholar
• Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, . Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis. Nucl Med Commun 2009;30:639–50.
   PubMedGoogle Scholar
• Cotton RE. The bronchial spread of lung cancer. Br J Disease Chest 1959;53:142–50.
   Google Scholar
• Kara M, Sak SD, Orhan D, Yavuzer S. Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin?Lung Cancer 2000;30:161–8.
   Google Scholar
• Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, . Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445–51.
   Google Scholar
• Pisansky TM, Davis BJ. Predictive factors in localized prostate cancer: Implications for radiotherapy and clinical trial design. Semin Urol Oncol 2000;18:93–107.
   Google Scholar
• Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, . Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?Int J Radiat Oncol Biol Phys 2006;65: 999–1007.
   Google Scholar
• Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988;139:1235–41.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Carmichael MJ, Pizov G, Walsh PC. Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup. J Urol 1993;150:135–41.
   PubMed Web of Science ®Google Scholar
• Davis BJ, Pisansky TM, Wilson TM, Rothenberg HJ, Pacelli A, Hillman DW, . The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy. Cancer 1999;85:2630–7.
   Web of Science ®Google Scholar
• Sohayda C, Kupelian PA, Levin HS, Klein EA. Extent of extracapsular extension in localized prostate cancer. Urology 2000;55:382–6.
   Google Scholar
• Teh BS, Bastasch MD, Mai WY, Butler EB, Wheeler TM. Predictors of extracapsular extension and its radial distance in prostate cancer: Implications for prostate IMRT, brachytherapy, and surgery. Cancer J 2003;9:454–60.
   Google Scholar
• Teh BS, Bastasch MD, Wheeler TM, Mai WY, Frolov A, Uhl BM, . IMRT for prostate cancer: Defining target volume based on correlated pathologic volume of disease. Int J Radiat Oncol Biol Phys 2003;56:184–91.
   PubMed Web of Science ®Google Scholar
• Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, . Prediction of radial distance of extraprostatic extension from pretherapy factors. Int J Radiat Oncol Biol Phys 2007;69:411–8.
   Google Scholar
• Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459–66.
   PubMed Web of Science ®Google Scholar
• Jansen EP, Dewit LG, van Herk M, Bartelink H. Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 2000;56:151–6.
   PubMed Web of Science ®Google Scholar
• Seither RB, Jose B, Paris KJ, Lindberg RD, Spanos WJ. Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995;18:297–9.
   Google Scholar
• Nelson DF, Curran Jr WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, . Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302. Int J Radiat Oncol Biol Phys 1993; 25:193–207.
   PubMed Web of Science ®Google Scholar
• Urtasun RC, Kinsella TJ, Farnan N, DelRowe JD, Lester SG, Fulton DS. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: Final report of RTOG 86-12, phase I–II study. Int J Radiat Oncol Biol Phys 1996;36:1163–7.
   PubMed Web of Science ®Google Scholar
• Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, . Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 2007;68: 144–50.
   PubMed Web of Science ®Google Scholar
• Matsuo M, Miwa K, Tanaka O, Shinoda J, Nishibori H, Tsuge Y, . Impact of [(11)C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. Int J Radiat Oncol Biol Phys 2012;82:83–90.
   Google Scholar
• Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, . Cerebral glioma: Evaluation with methionine PET. Radiology 1993;186:45–53.
   PubMed Web of Science ®Google Scholar
• Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, . Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010; 97:377–81.
   PubMed Web of Science ®Google Scholar
• Engenhart R, Kimmig BN, Hover KH, Wowra B, Romahn J, Lorenz WJ, . Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 1993;71:1353–61.
   PubMedGoogle Scholar
• Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, . Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563–9.
   PubMed Web of Science ®Google Scholar
• Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, . Stereotactic radiosurgery for the treatment of brain metastases. Cancer 1997;79:551–7.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, . Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006;295:2483–91.
   PubMed Web of Science ®Google Scholar
• Noel G, Simon JM, Valery CA, Cornu P, Boisserie G, Hasboun D, . Radiosurgery for brain metastasis: Impact of CTV on local control. Radiother Oncol 2003;68:15–21.
   Google Scholar
• Nataf F, Schlienger M, Liu Z, Foulquier JN, Gres B, Orthuon A, . Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 2008;70:766–72.
   Google Scholar
• Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, . Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008;70:187–93.
   PubMed Web of Science ®Google Scholar
• Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GRt, Lieberson RE, . Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: Prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys Epub2012 May 30.
   Google Scholar
• Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, . A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2006;66:187–94.
   PubMed Web of Science ®Google Scholar
• Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, . Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 2009;110:730–6.
   PubMed Web of Science ®Google Scholar
• Raore B, Schniederjan M, Prabhu R, Brat DJ, Shu HK, Olson JJ. Metastasis infiltration: An investigation of the postoperative brain-tumor interface. Int J Radiat Oncol Biol Phys 2010;81:1075–80.
   Google Scholar
• Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979–90.
   PubMed Web of Science ®Google Scholar
• Kirby AM, Coles CE, Yarnold JR. Target volume definition for external beam partial breast radiotherapy: Clinical, pathological and technical studies informing current approaches. Radiother Oncol 2010;94:255–63.
   PubMed Web of Science ®Google Scholar
• Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, . The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1988;14:3–10.
   PubMed Web of Science ®Google Scholar
• Healey EA, Osteen RT, Schnitt SJ, Gelman R, Stomper PC, Connolly JL, . Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer?Int J Radiat Oncol Biol Phys 1989;17:1217–21.
   Google Scholar
• Eberlein TJ, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris JR. Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg 1990;125:771–5; discussion 775–7.
   Google Scholar
• Vicini FA, Eberlein TJ, Connolly JL, Recht A, Abner A, Schnitt SJ, . The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991;214:200–4; discussion 204–5.
   PubMed Web of Science ®Google Scholar
• Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, . The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990;8:113–8.
   PubMed Web of Science ®Google Scholar
• Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH .Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519–22.
   PubMed Web of Science ®Google Scholar
• Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, . Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995;76: 32–45.
   Google Scholar
• Imamura H, Haga S, Shimizu T, Watanabe O, Kinoshita J, Nagumo H, . Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 2000;62:177–84.
   Google Scholar
• Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep 2008;10:54–60.
   Google Scholar
• Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, . Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990;19:29–41.
   PubMed Web of Science ®Google Scholar
• Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, . Accelerated treatment of breast cancer. J Clin Oncol 2001;19:1993–2001.
   PubMed Web of Science ®Google Scholar
• Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003;95:1205–10.
   PubMedGoogle Scholar
• Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int J Radiat Oncol Biol Phys 2004;60:722–30.
   PubMed Web of Science ®Google Scholar
• Kirby AM, Evans PM, Nerurkar AY, Desai SS, Krupa J, Devalia H, . How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy?Radiother Oncol 2010;94:292–9.
   Google Scholar
• Hanbeukers B, Borger J, van den Ende P, van der Ent F, Houben R, Jager J, . Customized computed tomography-based boost volumes in breast-conserving therapy: Use of three-dimensional histologic information for clinical target volume margins. Int J Radiat Oncol Biol Phys 2009; 75:757–63.
   Google Scholar
• Stroom J, Schlief A, Alderliesten T, Peterse H, Bartelink H, Gilhuijs K. Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy. Int J Radiat Oncol Biol Phys 2009;74:898–905.
   PubMed Web of Science ®Google Scholar
• Ho CM, Ng WF, Lam KH, Wei WJ, Yuen AP. Submucosal tumor extension in hypopharyngeal cancer. Arch Otolaryngol Head Neck Surg 1997;123:959–65.
   PubMedGoogle Scholar
• Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002;53:1174–84.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, . CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227–36.
   PubMed Web of Science ®Google Scholar
• Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, . Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 2006;64:678–83.
   PubMed Web of Science ®Google Scholar
• Johnson JT, Barnes EL, Myers EN, Schramm VL, Jr., Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981;107:725–9.
   PubMedGoogle Scholar
• Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL, Jr., Thearle PB. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985;111:534–7.
   PubMedGoogle Scholar
• Snyderman NL, Johnson JT, Schramm VL, Jr., Myers EN, Bedetti CD, Thearle P. Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer 1985;56:1597–9.
   Google Scholar
• Jenkins P, Anjarwalla S, Gilbert H, Kinder R. Defining the clinical target volume for bladder cancer radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 2009;75: 1379–84.
   Google Scholar
• Wang W, Feng X, Zhang T, Jin J, Wang S, Liu Y, . Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy. Radiat Oncol 2010;5:73.
   Google Scholar
• Wang MH, Ji Y, Zeng ZC, Tang ZY, Fan J, Zhou J, . Impact factors for microinvasion in patients with hepatocellular carcinoma: Possible application to the definition of clinical tumor volume. Int J Radiat Oncol Biol Phys 2010;76:467–76.
   Google Scholar
• Hoffman MS, Gunesakaran S, Arango H, DeCesare S, Fiorica JV, Parsons M, . Lateral microscopic extension of squamous cell carcinoma of the vulva. Gynecol Oncol 1999;73:72–5.
   Google Scholar
• Choo R, Woo T, Assaad D, Antonyshyn O, Barnes EA, McKenzie D, . What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers?Int J Radiat Oncol Biol Phys 2005;62:1096–9.
   Google Scholar
• Fennimore IA, Simon NL, Bills G, Dryfhout VL, Schniederjan AM. Extension of ovarian tissue into the infundibulopelvic ligament beyond visual margins. Gynecol Oncol 2009;114:61–3.
   Google Scholar
• Hong TS, WA. Tome, Harari PM. Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol 2012;103:92–8.
   PubMed Web of Science ®Google Scholar